These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30938471)

  • 21. Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats.
    Dunford J; Lee AT; Morgan MM
    J Pain; 2021 Sep; 22(9):1040-1047. PubMed ID: 33727159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Behavioral and temperature effects of delta 9-tetrahydrocannabinol in human-relevant doses in rats.
    Smirnov MS; Kiyatkin EA
    Brain Res; 2008 Sep; 1228():145-60. PubMed ID: 18619424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesolimbic dopamine dysregulation as a signature of information processing deficits imposed by prenatal THC exposure.
    Sagheddu C; Traccis F; Serra V; Congiu M; Frau R; Cheer JF; Melis M
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 105():110128. PubMed ID: 33031862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or ∆9-tetrahydrocannabinol (THC).
    Bossong MG; Jansma JM; Bhattacharyya S; Ramsey NF
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():53-69. PubMed ID: 24380726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ
    Uttl L; Szczurowska E; Hájková K; Horsley RR; Štefková K; Hložek T; Šíchová K; Balíková M; Kuchař M; Micale V; Páleníček T
    Front Neurosci; 2018; 12():703. PubMed ID: 30405327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states.
    Fitoussi A; Zunder J; Tan H; Laviolette SR
    Eur J Neurosci; 2018 Jun; 47(11):1385-1400. PubMed ID: 29776015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of antipsychotic and propsychotic drugs on prepulse inhibition and locomotor activity in Roman high- (RHA) and low-avoidance (RLA) rats.
    Oliveras I; Sánchez-González A; Sampedro-Viana D; Piludu MA; Río-Alamos C; Giorgi O; Corda MG; Aznar S; González-Maeso J; Gerbolés C; Blázquez G; Cañete T; Tobeña A; Fernández-Teruel A
    Psychopharmacology (Berl); 2017 Mar; 234(6):957-975. PubMed ID: 28154892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.
    Zamberletti E; Beggiato S; Steardo L; Prini P; Antonelli T; Ferraro L; Rubino T; Parolaro D
    Neurobiol Dis; 2014 Mar; 63():35-47. PubMed ID: 24200867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment.
    Penman SL; Berthold EC; Mihalkovic A; Hammond N; McCurdy CR; Blum K; Eiden RD; Sharma A; Thanos PK
    Curr Pharm Des; 2023; 29(27):2149-2160. PubMed ID: 37114788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Δ9-tetrahydrocannabinol (Δ9-THC) administration after neonatal exposure to phencyclidine potentiates schizophrenia-related behavioral phenotypes in mice.
    Rodríguez G; Neugebauer NM; Yao KL; Meltzer HY; Csernansky JG; Dong H
    Pharmacol Biochem Behav; 2017 Aug; 159():6-11. PubMed ID: 28648819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antipsychotics improve Delta9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice.
    Nagai H; Egashira N; Sano K; Ogata A; Mizuki A; Mishima K; Iwasaki K; Shoyama Y; Nishimura R; Fujiwara M
    Pharmacol Biochem Behav; 2006 Jun; 84(2):330-6. PubMed ID: 16820196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic Δ9-tetrahydrocannabinol treatment has dose-dependent effects on open field exploratory behavior and [
    Freeman-Striegel L; Hamilton J; Kannappan R; Bell T; Robison L; Thanos PK
    Life Sci; 2023 Aug; 327():121825. PubMed ID: 37270168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Δ(9)-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats.
    Gatch MB; Forster MJ
    Psychopharmacology (Berl); 2016 May; 233(10):1901-10. PubMed ID: 26875756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat.
    Yanar K; Coskun ZM; Beydogan AB; Aydin S; Bolkent S
    J Cell Biochem; 2019 Sep; 120(9):16219-16228. PubMed ID: 31081965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice.
    Kinsey SG; Cole EC
    Eur J Pharmacol; 2013 Sep; 715(1-3):111-6. PubMed ID: 23769745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ
    Boggs DL; Cortes-Briones JA; Surti T; Luddy C; Ranganathan M; Cahill JD; Sewell AR; D'Souza DC; Skosnik PD
    J Psychopharmacol; 2018 Dec; 32(12):1308-1318. PubMed ID: 30255720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats.
    Mansbach RS; Rovetti CC; Winston EN; Lowe JA
    Psychopharmacology (Berl); 1996 Apr; 124(4):315-22. PubMed ID: 8739546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.